Share

March 03, 2015; 84 (9) Article

Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease

Kristiina Rannikmäe, Gail Davies, Pippa A. Thomson, Steve Bevan, William J. Devan, Guido J. Falcone, Matthew Traylor, Christopher D. Anderson, Thomas W.K. Battey, Farid Radmanesh, Ranjan Deka, Jessica G. Woo, Lisa J. Martin, Jordi Jimenez-Conde, Magdy Selim, Devin L. Brown, Scott L. Silliman, Chelsea S. Kidwell, Joan Montaner, Carl D. Langefeld, Agnieszka Slowik, Björn M. Hansen, Arne G. Lindgren, James F. Meschia, Myriam Fornage, Joshua C. Bis, Stéphanie Debette, Mohammad A. Ikram, Will T. Longstreth, Reinhold Schmidt, Cathy R. Zhang, Qiong Yang, Pankaj Sharma, Steven J. Kittner, Braxton D. Mitchell, Elizabeth G. Holliday, Christopher R. Levi, John Attia, Peter M. Rothwell, Deborah L. Poole, Giorgio B. Boncoraglio, Bruce M. Psaty, Rainer Malik, Natalia Rost, Bradford B. Worrall, Martin Dichgans, Tom Van Agtmael, Daniel Woo, Hugh S. Markus, Sudha Seshadri, Jonathan Rosand, Cathie L.M. Sudlow
First published February 4, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001309
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
947

Share

Article Information

vol. 84 no. 9 918-926
DOI: 
https://doi.org/10.1212/WNL.0000000000001309
PubMed: 
25653287
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 24, 2014
  • Accepted in final form November 12, 2014
  • First Published February 4, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Kristiina Rannikmäe, MD,
    2. Gail Davies, PhD,
    3. Pippa A. Thomson, PhD,
    4. Steve Bevan, BSc, PhD,
    5. William J. Devan, BSc,
    6. Guido J. Falcone, MD, ScD, MPH,
    7. Matthew Traylor, MSc,
    8. Christopher D. Anderson, MD, MMSc,
    9. Thomas W.K. Battey, BS,
    10. Farid Radmanesh, MD, MPH,
    11. Ranjan Deka, PhD,
    12. Jessica G. Woo, PhD,
    13. Lisa J. Martin, MD,
    14. Jordi Jimenez-Conde, MD, PhD,
    15. Magdy Selim, MD, PhD,
    16. Devin L. Brown, MD, MS,
    17. Scott L. Silliman, MD,
    18. Chelsea S. Kidwell, MD,
    19. Joan Montaner, MD, PhD,
    20. Carl D. Langefeld, PhD,
    21. Agnieszka Slowik, MD,
    22. Björn M. Hansen, MD,
    23. Arne G. Lindgren, MD, PhD,
    24. James F. Meschia, MD,
    25. Myriam Fornage, PhD,
    26. Joshua C. Bis, PhD,
    27. Stéphanie Debette, MD, PhD,
    28. Mohammad A. Ikram, MD,
    29. Will T. Longstreth, MD,
    30. Reinhold Schmidt, MD,
    31. Cathy R. Zhang, MA,
    32. Qiong Yang, PhD,
    33. Pankaj Sharma, MD, PhD, FRCP,
    34. Steven J. Kittner, MD,
    35. Braxton D. Mitchell, PhD,
    36. Elizabeth G. Holliday, PhD,
    37. Christopher R. Levi, MD,
    38. John Attia, MD,
    39. Peter M. Rothwell, FMedSci,
    40. Deborah L. Poole, BSc,
    41. Giorgio B. Boncoraglio, MD,
    42. Bruce M. Psaty, MD, PhD,
    43. Rainer Malik, PhD,
    44. Natalia Rost, MD,
    45. Bradford B. Worrall, MD, MSc,
    46. Martin Dichgans, MD,
    47. Tom Van Agtmael, PhD,
    48. Daniel Woo, MD,
    49. Hugh S. Markus, DM,
    50. Sudha Seshadri, MD,
    51. Jonathan Rosand, MD and
    52. Cathie L.M. Sudlow, MD, PhD
    53. On behalf of the METASTROKE Consortium, the CHARGE WMH Group, the ISGC ICH GWAS Study Collaboration, the WMH in Ischemic Stroke GWAS Study Collaboration, and the International Stroke Genetics Consortium
  1. Kristiina Rannikmäe, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Edinburgh and Lothians Health Foundation REMIND Fund and Stroke Research and Amenities Endowments Fund

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Gail Davies, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Pippa A. Thomson, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) The National Institute of Mental Health (NIMH) USA,1R01MH102068-01, Co-investigator, October 2013- September 2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Steve Bevan, BSc, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. William J. Devan, BSc,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Guido J. Falcone, MD, ScD, MPH,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS, Grant number P50NS061343, research fellow, 2013.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Matthew Traylor, MSc,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Christopher D. Anderson, MD, MMSc,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Fellowship in Therapeutic Development, Biogen Idec, Inc.

    Research Support, Government Entities:

    1. (1) NIH-NINDS K23 NS086873-01

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) American Brain Foundation Clinical Research Training Fellowship

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Thomas W.K. Battey, BS,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Farid Radmanesh, MD, MPH,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Ranjan Deka, PhD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Supported by the following grants: T32 NIEHS 010957-11 (Principal Investigator) 07/01/2011 - 06/30/2015; Molecular Epidemiology in Children?s Environmental Health Training Program R01 NIH HL093093 (Sub Contract PI) 09/01/2009 12/31/2014; Genome-Wide Association Study of Adiposity in Samoans P30 NIH ES006096 (Co-Investigator) 04/01/2008 - 03/31/2015; Center for Environmental Genetics R01 NIH NS036695 (Co-Investigator) 09/12/1997 - 06/30/2014; Genetic and Environmental Risk Factors for Hemorrhagic Stroke

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Jessica G. Woo, PhD,
    13. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) International Pediatric Hypertension Association, travel expenses to present at American Society for Hypertension meeting, 2013

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Mead Johnson Pediatric Nutrition Institute, Inc.

    Research Support, Government Entities:

    1. (1) NIH/NINDS R01 NS36695, Subcontract PI, 2008-2014.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Lisa J. Martin, MD,
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Frontiers in Applied Genetic Epidemiology, 2013 - present, Associate Editor

    Patents:

    1. Adiponectin for Treatment of Various Disorders, Patent # 8,314,061

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH/NINDS, R01 NS036695, Co-Investigator, 07/01/08 ? (2) NIH/ NIAID, U19 AI070235,PI, 09/15/06 ? 08/31/16 (3) NIH, U19 AI066738-07, Co-Investigator, 07/01/10 - 06/30/15 (4) NIH, R01 HL111459-01, Co-Investigator, 09/01/11 ? 08/31/16 (5) NIH/ NHLBI,R24 HL105333-01A1,Co-Investigator, 03/03/12-02/28/17 (6) NIH/NIAID, R21AI101375-01A1, Co-Investigator, 7/1/2012-6/30/2014 (7) NIH, R01 HL116906-01A1, Co-Investigator, 7/1/2013-6/30/2018

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Jordi Jimenez-Conde, MD, PhD,
    15. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. IMIM-Hospital del Mar, Adjunct Neurologist

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NINDS/NI, U01NS069208, Center PI,2011-14, (2) ISCIII/Spanish Government Grants, PI10/02064, PI, 2011-13

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. La Marat? TV3,76/C/2011, PI, 2012-15 Recercaixa 2013, JJ086116, PI, 2014-2016

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Magdy Selim, MD, PhD,
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Stroke - Co-editor; Controversies Section. 2010-present Translational Stroke Research - Editorial Board Member. 2011- present Interventional Neurology - Editorial Board Member. 2013- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. The Stroke Book; Cambridge University Press Neurology Emergencies; Oxford University Press

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS U01 NS074425 Principal Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  16. Devin L. Brown, MD, MS,
    17. Scientific Advisory Boards:

    1. Steering Committee Member, Northern Manhattan Initiative for Minority involvement in Clinical Trials (NIMICT) (U24MD006961)

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Wayne State University, honorarium for talk.

    Editorial Boards:

    1. (1) Neurology, editorial board member, 2008-present (2) Stroke, editorial board member, 2011-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. CVR Global, Inc, 12/12/08 ? 06/30/10, research grant.

    Research Support, Government Entities:

    1. AHRQ, R18 HS017690, Co-I, 12/1/09 ? 11/30/13 NINDS, R01 NS062675, PI, 06/15/09 ? 05/31/14 NHLBI, R01 HL098065, PI, 06/01/10 ? 05/31/14 NINDS, R01 NS070941, PI, 05/01/11 - 04/30/16 NIH, R01 DC012760, Co-I, 08/1/13 - 07/31/18 NINDS, U10NS086526, PI, 09/01/13 - 07/01/18

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Blue Cross Blue Shield of Michigan Foundation, (2) Michigan Department of Community Health

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  17. Scott L. Silliman, MD,
    18. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen Novartis Genzyme Schering Plough

    Research Support, Government Entities:

    1. NIH/NINDS -1 R01 NS 44876-01A2 2004-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  18. Chelsea S. Kidwell, MD,
    19. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board Member, Neurocritical Care Journal, 2003- present Editorial Board Member, Journal of Neuroimaging, 2004- present Editorial Board Member, Stroke Research and Treatment, 2009-present Editorial Board Member, Stroke, 2011-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Baxter, 2009-2012

    Research Support, Government Entities:

    1. NIH-NINDS, Co-Investigator P50 NS044378, 7/22/08-7/30/13 NIH-NINDS, PI U54 NS057405, 09/01/07-08/31/12 NIH-NINDS, Co-Investigator U01 NS069763, 7/1/10-6/30/15 NIH-NIMHD, Project PI, P60 MD006920 12/1/11-11/30/16

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  19. Joan Montaner, MD, PhD,
    20. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  20. Carl D. Langefeld, PhD,
    21. Scientific Advisory Boards:

    1. (2) Oklahoma Medical Research Foundation, Wake Forest Nonhuman Primate Center, Wake Forest Research Advisory Committee for IT

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (2)NIH; Alliance for Lupus Research Grant Reviewer Functional Genomics and Molecular Pathways; Scleroderma Foundation Grant Reviewer; Medical University of South Carolina, Rheumatology Research Conference; University of Tampa; Kings College, London; University of Alabama at Birmingham

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. University of Alabama at Birmingham grant on African American GWAS for Arthritis;

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH R01 NS36695, Genetic and Environmental Risk Factors for Hemorrhagic Stroke (Langefeld, PI of subcontract, 5% effort); NIH R21 DK097524, Genetic Architecture of Obesity and Inflammation in Hispanic Americans (Langefeld, Co-PI, 8% effort); NIH U01 NS069763-01, Minorities with Ischemic Stroke Study (ERICH) (Langefeld, PI Data Coordinating Center, 5% effort); NIH P01 AR048929, Gene Expression in Pediatric Arthritis (Thompson, PI; Langefeld, PI Data Analysis Core, 5% effort); NIH 1R01HL114587-01A1, Genetic Risk for Granulomatous Interstitial Lung Disease (Langefeld, PI of subcontract, 4% effort); NIH R01 HL092301, Whole Genome Association Analysis of the Diabetes Heart Study (Langefeld, Co-I, 7.5% effort); NIH R01 DL066358, Genetics of African American Type 2 Diabetes (Langefeld, Co-I, 5% effort); NIH R01 DK085175-11A1, Genetic & Epidemiologic Predictors of Glucose Homeostasis measures in Hispanics (Langefeld, Co-I, 5% effort); NIH R01 DK535391, Mapping Genes for NIDDM Nephropathy in African Americans (Langefeld, Co-I, 4% effort); NIH R01 DK090111- 01, Mapping Diabetes Susceptibility by expression traits in African Americans (Langefeld, Co-I, 10% effort); NIH R01DK070941, An Integrative Genomic Approach to APOL1- Associated Nephropathy (Freedman, PI; Langefeld, Co-I, 2% effort); NIH R01 HG007112, Exome sequencing to identify CVD risk variants in Hispanics and African Americans (Langefeld, Co-PI, 10% effort); NIH R01 DK71891, Subclinical CVD in African American Type 2 Diabetes (Langefeld, Co-I, 4% effort); NIH 5R01CA166825-02, New and Integrated Perspectives on modification of Tamoxifen Effectiveness (Langefeld Co-I, 3% effort); NIH 5R01HL119962-02, The Role of Hepatocyte ABCA1 in Lipid Metabolism and Transport (Langefeld, Co-I, 1% effort); NIH 1UG1CA189824-01, Wake Forest NCORP Research Base (Role Langefeld Co-I, 1% effort) NIH funding completed in past two years: NIH/NIAMS, Genetics of Juvenile Idiopathic Arthritis and Subtypes (Langefeld, PI); NIH/NIAMSD, Program Project in the Genetics of SLE (Langefeld PI Data Analysis Core); NIAMS, Gene Mapping in Women with Systemic Lupus Erythematosus (Langefeld PI subcontract); NIH, Lupus Nephritis and Renal Failure: A National Consortium to Explore the Genotypic Basis for Immune-Mediated ESRD (Langefeld PI Biostatistics and Bioinformatics Core); NIH/NIDDK, Subclinical CVD in African American Type 2 Diabetes (Langefeld, Co-I); NINDS, Genetic Epidemiology of Cerebrovascular Disease and Cognition in Diabetes (Langefeld, Co-I); NIH, Integration of Functional and Molecular Genetics to Identify Diabetes Genes (Langefeld, Co-I); NIH, Natural History of MYH9-Associated Nephropathy (Langefeld, Co-I); NINDS Cerebrovascular Disease and Cognitive Performance in African Americans (Langefeld, Co-I); NIH, Genomics of Lupus (SLEGEN P01) (Langefeld, PI of Biostatistics and Bioinformatics Core); Medical College of South Carolina (Langefeld, PI of subcontract for analysis).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alliance for Lupus Research, ALS Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (Expert witness for defendant)

  21. Agnieszka Slowik, MD,
    22. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  22. Björn M. Hansen, MD,
    23. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  23. Arne G. Lindgren, MD, PhD,
    24. Scientific Advisory Boards:

    1. (1)Astra Zeneca (2)Bristol-Myers Squibb (3)Boehringer Ingelheim (4)Sanofi (5)Pfizer

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1)Astra Zeneca (2)Bristol-Myers Squibb (3)Boehringer Ingelheim (4)Sanofi (5)Pfizer

    Editorial Boards:

    1. (1) Neurologi i Sverige. 2011-2014. Editorial advisory board member.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  24. James F. Meschia, MD,
    25. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. On the editorial boards of Mayo Clinic Proceedings and of Stroke.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS, grant R01 NS038384

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  25. Myriam Fornage, PhD,
    26. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  26. Joshua C. Bis, PhD,
    27. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  27. Stéphanie Debette, MD, PhD,
    28. Scientific Advisory Boards:

    1. Scientific advisory board for the French National Recommendations on secondary stroke prevention (Haute Autorit? de Sant?, non-profit entity)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. editorial board of stroke

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Agence Nationale de la Recherche (French National Research Agency): chaire d'excellence junior 2010-2014; VASCOGENE project 2015-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Leducq Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  28. Mohammad A. Ikram, MD,
    29. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Neuroepidemiology, Editorial board member, 2011-2014, (2) PLoS One, Academic Editor, 2013-2014

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) ZonMW, 916.13.054, PI, 2012-2016, (2) STW, #12723, PI, 2013-2017, (3) BBMRI, CP2013-67, PI, 2013-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Alzheimer Association, 2014-NIRG-305710, (2) Internationale Stichting Alzheimer Onderzoek, #12533, (3) Nederlandse Hartstichting, 2012T008 and 2009B102, (4) Stichting ParkinsonFonds, (5) Institute for scientific information on coffee, (6) Alzheimer Nederland Fellowship

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  29. Will T. Longstreth, MD,
    30. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Dr. Longstreth is a co-investigator on several NIH-funded studies.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  30. Reinhold Schmidt, MD,
    31. Scientific Advisory Boards:

    1. Rivastigmin Patch, 2010, Novartis JSW Life Sciences 2010, Advisory Board for Dementia Trial Axon Neuroscience 2013 and 2014

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Received travel expenses and/or honoraria for lectures from Pfizer (2004-2010), Novartis (2003-2010), Merz Austria (2005-2010) and Lundbeck (2004-2009) and for educational activity from Takeda 2010

    Editorial Boards:

    1. Editoral board member of Clinical Neurology and Neurosurgery 2004-currently

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Pfizer 2004-2010,lectures Novartis 2003-2010,2014 lectures Merz Austria 2005-2010, lectures Lundbeck 2004-2009, lectures Takeda, 2010, teaching course

    Consultancies:

    1. QPS, Austria Axon Neuroscience

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Austrian Science Fund projects P20103 and I904

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  31. Cathy R. Zhang, MA,
    32. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  32. Qiong Yang, PhD,
    33. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  33. Pankaj Sharma, MD, PhD, FRCP,
    34. Scientific Advisory Boards:

    1. Bohringer 2009 & 2013 advisory board member 2013-14 Bayer advisory board member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. J Royal Soc Medicine Cardiovascular Disease Editor in Chief

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  34. Steven J. Kittner, MD,
    35. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board, Neuroepidemiology, 2000- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS: 1U01NS069208, Co-PI, 2010-2013 NINDS: R01NS069763-01, Site PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  35. Braxton D. Mitchell, PhD,
    36. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Diabetes, Associate Editor, 2009 - Diabetes/Metabolism Research and Reviews (Co-Editor, 2002-present) Diabetes Management (Editorial Advisory board, 2011-present)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. P60DK079637-02 (Wondisford) 03/05/13 ? 01/31/18 0.60 calendar NIH $250,000 (Johns Hopkins subcontract) Diabetes Research and Training Center In collaboration with Johns Hopkins University, the University of Maryland will develop a Baltimore Diabetes Research and Treatment Center to provide rational interventions for the effective treatment and prevention of diabetes and related diseases. P30 DK072488-06 (Shuldiner) 09/15/05 - 08/31/15 0.90 calendar NIH $807,956 Mid-Atlantic Nutrition Obesity Research Center The NORC will focus on the influence of nutrition and exercise on risk for age-related chronic diseases, including obesity, type 2 diabetes, hypertension, cardiovascular disease (CVD), sleep disordered breathing, and osteoporosis. U01HL105198-06 (Shuldiner) 04/10/10 ? 03/31/15 1.80 calendar NIH $1,941,032 Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study The major goal of this randomized clinical trial is to provide evidence base for translation of genotype-directed anti-platelet therapy into clinical practice. U01NS069208 (Kittner) 07/01/10 - 06/30/14 2.40 calendar NIH $449,701 The NINDS Ischemic Stroke Genetics Consortium The major goal of this project is to establish a consortium to perform a large sample size genome-wide association study for ischemic stroke using both previously genotyped and samples that need genotyping and to replicate and extend findings from discovery sample through international collaboration with other genome-wide association studies. R01MH085646-01 (Hong) 07/01/10 ? 05/31/201 0.60 calendar NIH $377,779 Neural Oscillatory Biomarkers for Genetics and Animal Model Schizophrenia This application proposes to critically examine the relevance of neural oscillatory response in the genetics of schizophrenia and test the overall hypothesis that neural oscillatory signals may serve as key biomarkers for the genetics and translational studies for schizophrenia R01DK088231-01 (Gerhard) 12/01/10 ? 11/30/15 0.50 calendar NIH $120,586 (sub with Geisinger Clinic) Genetic Determinants of Weight Loss and Resolution of Co-Morbidities The goal of this project is to identify common and rare gene variants that are associated with weight loss and improvement in metabolic traits following bariatric surgery. R01 AR052873-07 (Abramson) 07/01/12-06/30/17 0.60 calendar NIH $40,565 (UMD subcontract) Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression This project seeks to identify inflammation-related genetic, proteomic, and lipidomic biomarkers that predict progression of osteoarthritis in symptomatic patients. MITCHELL, Braxton D. (active continued) R01 EB015611-01 (Kochunov) 08/01/12 ? 07/31/15 0.60 calendar NIH $859,322 SOLAR-Eclipse Computational Tools for Imaging Genetics The goal of this study is to develop tools and computational methods for integrating and analyzing multidimensional imaging data in genetic studies. P30 NR014129-01 (Dorsey) 09/27/12 ? 08/31/17 0.60 calendar NIH $45,284 (Genomics Core only) Center for Genomics of Pain This center provides support for investigators at the University of Maryland seeking to use genomic approaches to understand the etiology and treatment of pain. R01 NS073346 (Shuldiner) 03/15/11 ? 02/28/14 0.90 calendar NIH $94,309 (UMD subcontract) Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy Timing The goal of this project is to identify genetic determinants of recurrent stroke, including those mediated by response to clopidogrel and other antiplatelet agents. No number (Puett, Mitchell, Co-PIs) 08/01/13-07/31/14 0 calendar Univ Maryland Research and Innovation Seed Program $70,660 Ambient Air pollution and Metabolic Syndrome in the Lancaster County Amish This project will develop preliminary data on the relationship of air pollution exposures, using state of the art spatio-temporal statistical models, and their relationship to metabolic and cardiovascular health in this unique population of Old Order Amish. R01 HL121007-01 (Mitchell) 01/15/14-11/30/17 1.56 calendar NIH $276,108 Identification and Functional Characterization of a Gene Influencing LDL-C on 5q

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  36. Elizabeth G. Holliday, PhD,
    37. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Australian National Health and Medical Research Council (NHMRC), APPID 631096, Chief Investigator, 2010-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  37. Christopher R. Levi, MD,
    38. Scientific Advisory Boards:

    1. Apixaban Scientific Advisory Board - Pfizer National Stroke Foundation (Australia) Research Advisory Committee

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Received travel expenses and/or honoraira for lectures or educational activities not funded by industry

    Editorial Boards:

    1. Advisory Board - Medicine Today, Since 2009 Associate Editor - BMC Neurology, Since 2011

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Expert External Reviewer - Stroke and Neurology Service, The Alfred Hospital, Melbourne. 2012

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHMRC Practitioner Fellowship 2013-17 NHMRC Project and Partnership Grants 2000-2017 Australian Brain Foundation Project Grants

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Stroke Foundation, Australia

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  38. John Attia, MD,
    39. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  39. Peter M. Rothwell, FMedSci,
    40. Scientific Advisory Boards:

    1. Exec Committee of the ARRIVE trial - payment for time.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Unpaid editorial board roles for Trials, Lancet Neurology, BMJ and International Journal of Stroke.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Too many to list - but all are non-commercial and none have any relationship to this study.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Too many to list - but all are non-commercial and none have any relationship to this study.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  40. Deborah L. Poole, BSc,
    41. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  41. Giorgio B. Boncoraglio, MD,
    42. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  42. Bruce M. Psaty, MD, PhD,
    43. Scientific Advisory Boards:

    1. Psaty serves on the DSMB of a clinical trial for a device funded by the manufacturer (Zoll LifeCor) and on the Steering Committee for the Yale Open Data Access project funded by Johnson & Johnson.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Contributing writer for JAMA.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Listed in the acknowledgement

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  43. Rainer Malik, PhD,
    44. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  44. Natalia Rost, MD,
    45. Scientific Advisory Boards:

    1. (1) Genzyme Co. (2) Daiichi Sankyo

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Daiichi Sankyo, travel/speaker honoraria

    Editorial Boards:

    1. Stroke, Assistant Editor, 2010

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS K23NS064052 (PI), 2009-2014 NIH/NINDS R01NS082285 (PI), 2013 -current

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National Stroke Association (2) American Stroke Association-Bugher Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  45. Bradford B. Worrall, MD, MSc,
    46. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology: Associate Editor 1 July 2009 - present Seminars in Neurology Editorial Board 2006-2014

    Patents:

    1. NONE

    Publishing Royalties:

    1. Chapter Author for Merritt's Neurology editions 10, 11, and 12.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS/NIH U-01 (RFA-NS-09-002) The NINDS International Stroke Genetics Consortium Study; Co-Principal Investigator, co-Chair of Phenotyping core; 3/31/10- 8/31/15 NHGRI/NIH U-01 HG005160 Pharmocogenomic studies in VISP: results and implications for clinical trial design - Part of the Genomics and Randomized Trials Network (GARNET); Co-Principal Investigator, Co-chair phenotype harmonization subcommittee, Chair incidental findings subcommittee, Member of Steering and Publications committees; 9/09-1/31/14 NINDS/NIH U01 NS NS069763 The Ethic/ Racial varieation in IntraCerebral Hemorrhage (ERICH) study - Daniel Woo PI. Site Investigator NHLBI (contract no grant #) Cardiovascular Substudy to Age-Related Eye Disease Study 2 (AREDS2); Principal Investigator, cerebrovascular outcomes adjudicator; 01/01/09- 12/31/12 NINDS - R25 NS065733 NINDS Research Education program for Residents and Fellows at the University of VA; Mentor; March 2009- February 2014 NINDS/NIH- R01 NS42147 Discovery for Warfarin-Related Intracerebral Hemorrhage (GOCHA); Site PI; 12/04-8/14 NINDS/NIH- R01 NS039512 Familial Intracranial Aneurysm Study (FIA) ; Executive committee member, site co-investigator; 2/1/99-8/31/13

    Research Support, Academic Entities:

    1. University of Virginia - CENETERS OF EXCELLENCE CLINICAL RESEARCH GRANT SUPPORT - The UVA BRAIN AND AORTIC ANEURYSM SCREENING (BAAS) study - Prinicpal Investigator 10/13-9/15

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  46. Martin Dichgans, MD,
    47. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Bayer Vital, travel expenses and honoraria for lectures, (2) Boehringer Ingelheim Pharma, travel expenses and honoraria for lectures, (3) Heel, travel expenses and honoraria for lectures, (4) Bristol-Meyer Squibb, travel expenses and honoraria for lectures, (5) Lundeck, travel expenses and honoraria for lectures, (6) Sanofi- Aventis, travel expenses and honoraria for lectures, (7) Shire, travel expenses and honoraria for lectures, (8) German Research Foundation (DFG), research support, (9) Vascular Dementia Research Foundation, research support, (10) Corona Foundation, research support, (11) Jackst?dt Foundation, research support.

    Editorial Boards:

    1. (1) Stroke the International Journal of Stroke, editor, (2) Cerebrovascular diseases, editorial board member, (3) Journal of Neurochemistry, editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol- Meyer Squibb, (4) Heel

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Wellcometrust, 03/08 following, (2) European Union (EU FP 7), investigator, 10/13-09/16, (3) German Federal Ministry of Education and Research (BMBF), investigator, 12/13-11/16, (4) European Union (EU FP 6), investigator, 03/12-02/15

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Vascular Dementia Research Foundation, (2) Corona Foundation, (3) Jackst?dt Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  47. Tom Van Agtmael, PhD,
    48. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Kidney Research UK Grant number (RP19/2012)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  48. Daniel Woo, MD,
    49. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Stroke Research and Treatment, Associate Editor, 2010-2014.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH Funding: NS36695 (PI: 1998-Current); NS30678 (CoI: 1998-Current). NS69763 (PI: 2010-Current).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  49. Hugh S. Markus, DM,
    50. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Section editor International Journal of stroke editorial board Clin Neurology and Neurosurgery

    Patents:

    1. NONE

    Publishing Royalties:

    1. Stroke Medicine OUP. 2010

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS for SIGN genetics grant

    Research Support, Academic Entities:

    1. Stroke Association, EU, Wellcome Trust, The British Heart Foundation, Alzheimer Research for peer reviewed research grants

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  50. Sudha Seshadri, MD,
    51. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer's Disease, Associate Editor since 2005. Stroke: Editorial Board since 2010. Neurology: Editorial Board since 2011.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NIA: Grant number: R01 AG08122 (PI: Seshadri, Wolf); role: PI (Multiple PI grant) 08/01/10-07/31/16; NIH/NINDS: Grant number R01 NS017950 (Wolf); role: investigator; 07/01/09-6/31/14; NIH/NIA: 1 R01 AG033040-01 (PI: Wolf); role: investigator; 01/15/09-12/31/13; NIH/NIA: Grant number: R01 AG033193(PI: Seshadri); 02/01/09-01/31/17 NIH/NIA: Grant Number: U01 AG49505 (PI: Seshadri) 08/01/14-08/01/18

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  51. Jonathan Rosand, MD and
    52. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Lancet Neurology, editorial board member Stroke, editorial board member

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Boehringer Ingelheim

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS, R01NS059727 NINDS, R01NS073344 NINDS, U01NS069208 NINDS, U01NS069763

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Boehringer Ingelheim, consultant

  52. Cathie L.M. Sudlow, MD, PhD
    53. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Scottish Executive Health Department 01/04/2008-2013 Chief Scientist Office Project Grant (co-applicant) (principal investigator Dr Brian McKinstry, University of Edinburgh) ?Telemetric supported self-monitoring of long-term conditions.'

    Research Support, Academic Entities:

    1. (1) British Heart Foundation 2012-2017 RESTART trial of antiplatelet treatment in ICH ( co- applicant) (2) UKBiobank 01/05/2012-ongoing Stroke Outcomes Pilot (principal applicant) (3) UK Biobank 01/09/2012-ongoing chief scientist support (principal applicant) (4) NIH via University of Maryland Stroke GWAS sub award for stroke phenotyping 01/06/2011-31/12/2013

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Authors' affiliations are listed at the end of the article.
  1. Correspondence to Dr. Sudlow: cathie.sudlow{at}e.ac.uk

Article usage

Article usage: February 2015 to October 2023

AbstractFullPdfSource
Feb 2015479065Highwire
Mar 201516333647Highwire
Apr 20152162329Highwire
May 20159259Highwire
Jun 20156196Highwire
Jul 20158457Highwire
Aug 201551139Highwire
Sep 20156374Highwire
Sep 201503119pmc
Oct 20154674Highwire
Oct 201505836pmc
Nov 2015471212Highwire
Nov 201504125pmc
Dec 20155132Highwire
Dec 201505214pmc
Jan 20165144Highwire
Jan 201603218pmc
Feb 20164621Highwire
Feb 201603521pmc
Mar 20165702Highwire
Mar 201604422pmc
Apr 20165526Highwire
Apr 201602214pmc
May 20166883Highwire
May 201602113pmc
Jun 20163935Highwire
Jun 201602414pmc
Jul 20162142Highwire
Jul 201603512pmc
Aug 20163987Highwire
Aug 201603018pmc
Sep 20163212Highwire
Sep 201602211pmc
Oct 20164622Highwire
Oct 20160216pmc
Nov 20166132Highwire
Nov 201602817pmc
Dec 20164220Highwire
Dec 201603218pmc
Jan 20174634Highwire
Jan 201703217pmc
Feb 201732910Highwire
Feb 201702412pmc
Mar 20173221Highwire
Mar 201702610pmc
Apr 20173322Highwire
Apr 2017101110pmc
May 20172533Highwire
May 2017192732pmc
Jun 20172014Highwire
Jun 2017152223pmc
Jul 20171401Highwire
Jul 2017122221pmc
Aug 20171811Highwire
Aug 201791621pmc
Sep 20172001Highwire
Sep 2017121824pmc
Oct 20173124Highwire
Oct 201782120pmc
Nov 20171422Highwire
Nov 2017112224pmc
Dec 20171811Highwire
Jan 20182954Highwire
Feb 20183112Highwire
Mar 201874532Highwire
Apr 20184341Highwire
Apr 201851717pmc
May 20185500Highwire
Jun 20183700Highwire
Jun 201872235pmc
Jul 20181710Highwire
Aug 20183911Highwire
Aug 2018133036pmc
Sep 20182220Highwire
Oct 20182600Highwire
Nov 20182852Highwire
Dec 20181523Highwire
Jan 20191531Highwire
Feb 20193053Highwire
Mar 20192311Highwire
Apr 2019830Highwire
May 201927115Highwire
Jun 20192332Highwire
Jul 20192030Highwire
Aug 20191730Highwire
Sep 20191541Highwire
Oct 20194133Highwire
Nov 20193470Highwire
Dec 20192262Highwire
Jan 20202411Highwire
Feb 20201801Highwire
Mar 20202620Highwire
Apr 20202730Highwire
May 20203731Highwire
Jun 20203800Highwire
Jul 20202421Highwire
Aug 20202701Highwire
Sep 20203300Highwire
Oct 20204211Highwire
Nov 20207942Highwire
Dec 20201621Highwire
Jan 20216952Highwire
Feb 20213921Highwire
Mar 20216522Highwire
Apr 20215230Highwire
May 202110491Highwire
Jun 20213910Highwire
Jul 20217150Highwire
Aug 20215040Highwire
Sep 20214612Highwire
Oct 20213550Highwire
Nov 20215433Highwire
Dec 20216236Highwire
Jan 20227912Highwire
Feb 20227923Highwire
Mar 20226074Highwire
Apr 20228595Highwire
May 20227131Highwire
Jun 20226554Highwire
Jul 20224702Highwire
Aug 20223211Highwire
Sep 20226332Highwire
Oct 20224154Highwire
Nov 20226120Highwire
Dec 20228440Highwire
Jan 20236150Highwire
Feb 20237631Highwire
Mar 20238111Highwire
Apr 20238053Highwire
May 20234910Highwire
Jun 20235565Highwire
Jul 20235323Highwire
Aug 20235122Highwire
Sep 20235821Highwire
Oct 202310820Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles